Article Information
History
- January 11, 2022.
Article Versions
- Version 1 (March 8, 2021 - 04:19).
- Version 2 (May 29, 2021 - 23:18).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Evgeny N. Mikhaylov, MD, PhD1,*,
- Tamara A. Lyubimtseva, MD, PhD1,
- Aleksandr D. Vakhrushev, MD1,
- Dmitry Stepanov, MD, DESA2,
- Dmitry S. Lebedev, MD, PhD1,
- Elena Yu. Vasilieva, MD1,
- Alexandra O. Konradi, MD, PhD1 and
- Evgeny V. Shlyakhto, MD, PhD1
- 1Almazov National Medical Research Centre, Saint-Petersburg, Russia
- 2Department of Anesthesiology, Intensive Care, Pain Management and Palliative Care, Marienkrankenhaus Soest, Soest, Germany
- ↵*Address for correspondence:
Assoc. prof. Dr. Evgeny N. Mikhaylov, MD, PhD, Institute of Heart and vessels, Almazov National Medical Research Centre, 197341 Saint-Petersburg, Russian Federation;, Tel.: 007(812) 7023706, e-mail: e.mikhaylov{at}almazovcentre.ru
Authors ENM and TAL contributed equally to this work.
Posted January 11, 2022.
Bromhexine Hydrochloride Prophylaxis of COVID-19 for Medical Personnel: A Randomized Open-Label Study
